These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38293351)

  • 1. A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson's disease mouse model.
    Fu CL; Dong BC; Jiang X; Li D; Yao J
    Heliyon; 2024 Jan; 10(2):e24234. PubMed ID: 38293351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
    Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
    Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
    Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
    Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
    Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.
    Patikas N; Ansari R; Metzakopian E
    Neurosci Res; 2023 Oct; 195():13-28. PubMed ID: 37271312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Evaluation of Intranigral Transplantation of Human iPSC-Derived Dopamine Neurons in a Parkinson's Disease Mouse Model.
    Brot S; Thamrin NP; Bonnet ML; Francheteau M; Patrigeon M; Belnoue L; Gaillard A
    Cells; 2022 May; 11(10):. PubMed ID: 35626637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
    Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
    Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons.
    Peng SP; Schachner M; Boddeke E; Copray S
    Cell Reprogram; 2016 Apr; 18(2):55-66. PubMed ID: 26990843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson's disease.
    Nakamura R; Nonaka R; Oyama G; Jo T; Kamo H; Nuermaimaiti M; Akamatsu W; Ishikawa KI; Hattori N
    Front Neurosci; 2023; 17():1202027. PubMed ID: 37502682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
    Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
    Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
    Kriks S; Shim JW; Piao J; Ganat YM; Wakeman DR; Xie Z; Carrillo-Reid L; Auyeung G; Antonacci C; Buch A; Yang L; Beal MF; Surmeier DJ; Kordower JH; Tabar V; Studer L
    Nature; 2011 Nov; 480(7378):547-51. PubMed ID: 22056989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application.
    Hiramatsu S; Morizane A; Kikuchi T; Doi D; Yoshida K; Takahashi J
    J Parkinsons Dis; 2022; 12(3):871-884. PubMed ID: 34958047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
    de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
    Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.